Atlas Trials

Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca

Clinical trial NCT02144194 · UNKNOWN

Trial details

NCT number
NCT02144194
Sponsor
Cancer Research Group - Collaborative Group, Beirut, Lebanon.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2012-03-01
Primary completion
2017-06-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.